Clinical trial Recruiting at 1 site Observational Ages 21 and up

Observing the effects of kratom products on regular users

Official title: Observing the Acute Effects Following a Single Oral Dose of Kratom and Effects Following Kratom Cessation Among Adults Who Use Regularly.

Run by Johns Hopkins University · NCT06089980 · Data updated 2026-11-12

This study looks at how regular users of kratom feel and function after taking their usual dose, while also checking what happens when they stop using it.

Quick facts

Study typeObservational
Ages21 Years and up
SexAll
Enrollment22 (estimated)
SponsorJohns Hopkins University
Academic / other
Locations1 site (Baltimore, Maryland)
StatusRecruiting
StartedApril 1, 2024
Main results expectedFebruary 2028
Study endsFebruary 2028
Registry record updatedJanuary 23, 2026
Trial IDNCT06089980 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 21 who have been using kratom more than five times a week for at least three months.

Probably not a fit

Patients who have experienced acute adverse health events related to kratom use or have current dependencies on certain substances may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate the effects of commercial kratom products on healthy adults who consume them regularly. Participants will self-administer a single oral dose of their usual kratom product, and the study will assess the acute physiological, subjective, and cognitive effects of this dose. Additionally, the study will explore the effects of kratom product discontinuation and analyze the pharmacokinetics of kratom in regular users through blood draws and urine collection. The goal is to gather comprehensive data on how kratom affects users in real-time.

Why it matters

Potential benefit: If successful, this study could provide valuable insights into the safety and effects of kratom, potentially guiding better usage practices for consumers.

How similar studies have gone: While there is limited research specifically on kratom, studies on similar herbal products have shown varying degrees of success in understanding their effects.

Who can join: the full rules

Show full inclusion / exclusion criteria
INCLUSION CRITERIA:

1. \>21 years
2. reporting kratom use \>5 times per week for \>3 months prior to study screening
3. English language proficiency
4. Willingness to provide requested samples of the kratom product being currently taken

EXCLUSION CRITERIA:

1. Reports any acute adverse, unexpected, or otherwise sudden health event related to the typical kratom product dose that occurred within 30 days of screening
2. Having ever sought medical attention for an acute adverse health event as a result of taking any kratom product.
3. Cannot or will not provide kratom product samples in the form of an unopened package of kratom that is clearly labeled with at least the product and vendor name.
4. Self-reports using kratom products by any other route than orally swallowing.
5. Current physical dependence on alcohol, benzodiazepines, or opioids
6. Reports use of fentanyl within the past month and/or has a fentanyl positive drug screen.
7. Discordance between self-reported substance use and drug screen results obtained during screening.
8. Lifetime or current psychotic disorder
9. Current untreated major depressive or bipolar disorder
10. Pregnancy or nursing
11. Physical, psychiatric, or environmental conditions considered by study team to increase risk or undue burden (e.g., untreated hypertension, high BMI, etc.).

Where it's running

  • Johns Hopkins University
    Baltimore, Maryland, United States
    Recruiting

Study contacts

  • Principal investigator: Kirsten E Smith, Ph.D. — Johns Hopkins University
  • Study coordinator: Kirsten E Smith, Ph.D.
  • Email: ksmit398@jh.edu
  • Phone: 865-418-8177

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.